GoodRx Quarterly Balance Sheet
NASDAQ: GDRXTechnologyEDP ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GoodRx financial position
As of Jun 30, 2026, GoodRx reported total assets of $2.34 billion, up 77.7% from a year earlier against total liabilities of $1.70 billion. Shareholders' equity stood at $647.6 million, or 27.6% of assets. The company held $296.1 million in cash and equivalents against $486.6 million of debt, a net debt position of $190.5 million.
The current ratio (current assets divided by current liabilities) was 1.38, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.75.
Summary generated from market data by MetaCap's automated system. Methodology
GoodRx balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 296.11M | 235.71M | 261.82M | 273.53M | 281.32M | 300.98M | 448.35M | 423.78M | 524.90M | 533.29M | 672.30M | 794.90M |
| Receivables | 182.14M | 232.72M | 235.75M | 203.74M | 189.03M | 160.12M | 145.93M | 130.80M | 161.77M | 144.77M | 143.61M | 121.15M |
| Total Current Assets | 1.60B | 1.27B | 643.10M | 565.51M | 550.61M | 540.21M | 659.25M | 626.80M | 750.55M | 732.80M | 872.79M | 969.10M |
| Property, Plant & Equipment | 11.51M | 11.74M | 12.27M | 11.28M | 10.73M | 11.51M | 12.66M | 13.63M | 14.49M | 15.34M | 15.93M | 16.88M |
| Goodwill | 430.33M | 430.33M | 430.33M | 421.72M | 421.72M | 421.72M | 410.77M | 410.77M | 410.77M | 410.77M | 410.77M | 412.12M |
| Intangible Assets | 58.25M | 61.17M | 64.08M | 62.77M | 65.57M | 68.36M | 52.10M | 54.06M | 56.02M | 58.12M | 60.90M | 89.43M |
| Total Assets | 2.34B | 2.02B | 1.40B | 1.33B | 1.32B | 1.30B | 1.39B | 1.35B | 1.48B | 1.45B | 1.59B | 1.71B |
| Accounts Payable | 8.91M | 14.53M | 19.41M | 28.73M | 25.41M | 15.26M | 14.14M | 12.39M | 16.88M | 33.52M | 36.27M | 32.91M |
| Short-Term Debt | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | 3.75M | 7.03M | 7.03M | 8.79M | 7.03M |
| Total Current Liabilities | 1.16B | 859.20M | 246.00M | 181.86M | 130.91M | 103.38M | 123.90M | 114.36M | 102.47M | 116.52M | 122.56M | 117.82M |
| Long-Term Debt | 481.59M | 482.42M | 483.26M | 484.11M | 484.97M | 485.84M | 486.71M | 487.59M | 645.65M | 646.68M | 647.70M | 648.73M |
| Total Liabilities | 1.70B | 1.40B | 787.80M | 724.79M | 675.67M | 640.92M | 663.41M | 658.41M | 805.99M | 822.89M | 826.84M | 826.70M |
| Shareholders' Equity | 647.60M | 621.99M | 616.26M | 600.71M | 643.03M | 654.35M | 724.66M | 696.43M | 669.40M | 631.07M | 761.96M | 881.27M |
| Retained Earnings | -1.40B | -1.41B | -1.41B | -1.42B | -1.42B | -1.43B | -1.44B | -1.45B | -1.45B | -1.46B | -1.46B | -1.43B |
| Total Debt | 486.59M | 487.42M | 488.26M | 489.11M | 489.97M | 490.84M | 491.71M | 491.34M | 652.68M | 653.71M | 656.49M | 655.76M |
| Net Cash (Debt) | -190.47M | -251.71M | -226.44M | -215.59M | -208.65M | -189.86M | -43.37M | -67.57M | -127.77M | -120.41M | 15.81M | 139.15M |
This table shows 12 quarterly periods of GoodRx's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow GDRX's reporting calendar. What is a balance sheet?